Auto-immune thyroid dysfunction induced by tyrosine kinase inhibitors in a patient with recurrent chordoma View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-12

AUTHORS

Juliette Eroukhmanoff, Frederic Castinetti, Nicolas Penel, Sebastien Salas

ABSTRACT

BACKGROUND: While hypothyroidism has frequently been reported with the use of TKIs, the thyroid-stimulating hormone (TSH) suppressing effect of TKIs is rare, except for thyroiditis. We describe a case with progressive recurrent chordoma who initially became hyperthyroid in a context of autoimmunity under sorafenib treatment and later under imatinib treatment. CASE PRESENTATION: A 57-year-old man with lumbar chordoma began daily treatment of 800 mg sorafenib. He did not have any other medication or recent iodinated-contrast exposure and his family history was negative for thyroid and autoimmune disease. There was no history of neck pain, irradiation or trauma, recent fever or viral illness. Pre-treatment TSH was normal. After 18 weeks of treatment, the patient presented hyperthyroidism with positive anti-TSH receptor antibodies. More surprisingly, Graves' disease recurred during treatment with imatinib. CONCLUSION: The fact that Graves' disease occurred after two different TKIs suggests that it could be a rare but important class effect. Anti-TSH receptor antibodies should be systematically measured when TSH decreases in order to avoid the erroneous diagnosis of transient hyperthyroidism due to thyroiditis. More... »

PAGES

679

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12885-016-2705-3

DOI

http://dx.doi.org/10.1186/s12885-016-2705-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1010473172

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27558389


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chordoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Graves Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Imatinib Mesylate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Niacinamide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phenylurea Compounds", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Kinase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sorafenib", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "H\u00f4pital de la Conception", 
          "id": "https://www.grid.ac/institutes/grid.411535.7", 
          "name": [
            "Department of Medicine, Division of endocrinology, APHM, Conception Hospital, Marseille, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Eroukhmanoff", 
        "givenName": "Juliette", 
        "id": "sg:person.016217422035.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016217422035.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "H\u00f4pital de la Conception", 
          "id": "https://www.grid.ac/institutes/grid.411535.7", 
          "name": [
            "Department of Medicine, Division of endocrinology, APHM, Conception Hospital, Marseille, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Castinetti", 
        "givenName": "Frederic", 
        "id": "sg:person.01046211643.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046211643.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Medicine, Division of adult oncology, Oscar Lambret Institute, Lille, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Penel", 
        "givenName": "Nicolas", 
        "id": "sg:person.0677574257.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677574257.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "H\u00f4pital de la Timone", 
          "id": "https://www.grid.ac/institutes/grid.411266.6", 
          "name": [
            "Aix Marseille Univ, INSERM, U911, Marseille, France", 
            "Department of Medicine, Division of adult oncology, APHM, Timone Hospital, Marseille, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Salas", 
        "givenName": "Sebastien", 
        "id": "sg:person.0601021000.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601021000.78"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1530/eje-08-0648", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006092842"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdm483", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006370749"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2265.2008.03253.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013653892"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jjco/hys076", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015675456"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/14653240802317639", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019189330"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.molmed.2010.02.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025280461"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.molmed.2005.07.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029510803"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1016/j.clpt.2005.06.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031235907", 
          "https://doi.org/10.1016/j.clpt.2005.06.010"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000337086", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033631373"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2007-0586", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036876446"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa075853", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039978290"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12020-012-9683-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047428945", 
          "https://doi.org/10.1007/s12020-012-9683-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/djk008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047892911"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.urolonc.2009.08.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048723986"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/thy.2010.0070", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059320792"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/thy.2010.0234", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059320861"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/thy.2010.0251", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059320869"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/thy.2012.0378", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059321511"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/thy.2015.0170", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059322048"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2007-0649", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064289967"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-145-9-200611070-00008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073709000"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-12", 
    "datePublishedReg": "2016-12-01", 
    "description": "BACKGROUND: While hypothyroidism has frequently been reported with the use of TKIs, the thyroid-stimulating hormone (TSH) suppressing effect of TKIs is rare, except for thyroiditis. We describe a case with progressive recurrent chordoma who initially became hyperthyroid in a context of autoimmunity under sorafenib treatment and later under imatinib treatment.\nCASE PRESENTATION: A 57-year-old man with lumbar chordoma began daily treatment of 800\u00a0mg sorafenib. He did not have any other medication or recent iodinated-contrast exposure and his family history was negative for thyroid and autoimmune disease. There was no history of neck pain, irradiation or trauma, recent fever or viral illness. Pre-treatment TSH was normal. After 18\u00a0weeks of treatment, the patient presented hyperthyroidism with positive anti-TSH receptor antibodies. More surprisingly, Graves' disease recurred during treatment with imatinib.\nCONCLUSION: The fact that Graves' disease occurred after two different TKIs suggests that it could be a rare but important class effect. Anti-TSH receptor antibodies should be systematically measured when TSH decreases in order to avoid the erroneous diagnosis of transient hyperthyroidism due to thyroiditis.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12885-016-2705-3", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024632", 
        "issn": [
          "1471-2407"
        ], 
        "name": "BMC Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "16"
      }
    ], 
    "name": "Auto-immune thyroid dysfunction induced by tyrosine kinase inhibitors in a patient with recurrent chordoma", 
    "pagination": "679", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "31e511acfc365bfca268bf88db7e640c7c0466c44b432b766e82f7901565597a"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27558389"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100967800"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12885-016-2705-3"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1010473172"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12885-016-2705-3", 
      "https://app.dimensions.ai/details/publication/pub.1010473172"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:27", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000362_0000000362/records_87119_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs12885-016-2705-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12885-016-2705-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12885-016-2705-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12885-016-2705-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12885-016-2705-3'


 

This table displays all metadata directly associated to this object as RDF triples.

208 TRIPLES      21 PREDICATES      62 URIs      33 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12885-016-2705-3 schema:about N221dad8b71b345ce89fc0d916d4452b4
2 N27d2e4793ece43819662c25e9ccdeb90
3 N4624744527a04dd792dc5d32427d9f40
4 N5e97c09b5b1449adbaa5d6f88b78a368
5 N61526b23d16c4609aaf4a75ecbeada2a
6 N7ef0527a914245dfb4222fc00ed7a587
7 N84be816266d94b288149c290399ce588
8 N84fbaa0deeb84d96822415d05f3d9a35
9 N9e399ae794534d58b36c325494ea01e0
10 Nb2389af2a852489d9148c0b1dc0bb0ae
11 Ne7db580ab1944eb494f0871bfed05fab
12 Nec470ba382574c0c82d50d6e7c5d2d0e
13 anzsrc-for:11
14 anzsrc-for:1103
15 schema:author N4c7dd19badbd4611aba3e71da1864589
16 schema:citation sg:pub.10.1007/s12020-012-9683-2
17 sg:pub.10.1016/j.clpt.2005.06.010
18 https://doi.org/10.1016/j.molmed.2005.07.007
19 https://doi.org/10.1016/j.molmed.2010.02.001
20 https://doi.org/10.1016/j.urolonc.2009.08.011
21 https://doi.org/10.1056/nejmoa075853
22 https://doi.org/10.1080/14653240802317639
23 https://doi.org/10.1089/thy.2010.0070
24 https://doi.org/10.1089/thy.2010.0234
25 https://doi.org/10.1089/thy.2010.0251
26 https://doi.org/10.1089/thy.2012.0378
27 https://doi.org/10.1089/thy.2015.0170
28 https://doi.org/10.1093/annonc/mdm483
29 https://doi.org/10.1093/jjco/hys076
30 https://doi.org/10.1093/jnci/djk008
31 https://doi.org/10.1111/j.1365-2265.2008.03253.x
32 https://doi.org/10.1159/000337086
33 https://doi.org/10.1210/jc.2007-0586
34 https://doi.org/10.1210/jc.2007-0649
35 https://doi.org/10.1530/eje-08-0648
36 https://doi.org/10.7326/0003-4819-145-9-200611070-00008
37 schema:datePublished 2016-12
38 schema:datePublishedReg 2016-12-01
39 schema:description BACKGROUND: While hypothyroidism has frequently been reported with the use of TKIs, the thyroid-stimulating hormone (TSH) suppressing effect of TKIs is rare, except for thyroiditis. We describe a case with progressive recurrent chordoma who initially became hyperthyroid in a context of autoimmunity under sorafenib treatment and later under imatinib treatment. CASE PRESENTATION: A 57-year-old man with lumbar chordoma began daily treatment of 800 mg sorafenib. He did not have any other medication or recent iodinated-contrast exposure and his family history was negative for thyroid and autoimmune disease. There was no history of neck pain, irradiation or trauma, recent fever or viral illness. Pre-treatment TSH was normal. After 18 weeks of treatment, the patient presented hyperthyroidism with positive anti-TSH receptor antibodies. More surprisingly, Graves' disease recurred during treatment with imatinib. CONCLUSION: The fact that Graves' disease occurred after two different TKIs suggests that it could be a rare but important class effect. Anti-TSH receptor antibodies should be systematically measured when TSH decreases in order to avoid the erroneous diagnosis of transient hyperthyroidism due to thyroiditis.
40 schema:genre research_article
41 schema:inLanguage en
42 schema:isAccessibleForFree true
43 schema:isPartOf N54aa97890dde4880bf20ec8237e22aa6
44 Nfae1e6bf2d8b47c4ab8f083bcc13d249
45 sg:journal.1024632
46 schema:name Auto-immune thyroid dysfunction induced by tyrosine kinase inhibitors in a patient with recurrent chordoma
47 schema:pagination 679
48 schema:productId N2fa064a534c94ded8c4387f299e22e21
49 N6013503c17e54823b0fcfa3b68ad2350
50 N61a3382a854e43d49c19db3716e218c6
51 N878276fe1d604d72aa9ee633942ac303
52 Ncf6037ab74424d32a7e8fa02680e96fc
53 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010473172
54 https://doi.org/10.1186/s12885-016-2705-3
55 schema:sdDatePublished 2019-04-11T12:27
56 schema:sdLicense https://scigraph.springernature.com/explorer/license/
57 schema:sdPublisher N7497a794e4de4c7e8ef6686a3381585a
58 schema:url https://link.springer.com/10.1186%2Fs12885-016-2705-3
59 sgo:license sg:explorer/license/
60 sgo:sdDataset articles
61 rdf:type schema:ScholarlyArticle
62 N221dad8b71b345ce89fc0d916d4452b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
63 schema:name Phenylurea Compounds
64 rdf:type schema:DefinedTerm
65 N27d2e4793ece43819662c25e9ccdeb90 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
66 schema:name Humans
67 rdf:type schema:DefinedTerm
68 N2fa064a534c94ded8c4387f299e22e21 schema:name doi
69 schema:value 10.1186/s12885-016-2705-3
70 rdf:type schema:PropertyValue
71 N4624744527a04dd792dc5d32427d9f40 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Neoplasm Recurrence, Local
73 rdf:type schema:DefinedTerm
74 N4c7dd19badbd4611aba3e71da1864589 rdf:first sg:person.016217422035.81
75 rdf:rest Nf8f0dddf5700435ea8507b519ab4392d
76 N54aa97890dde4880bf20ec8237e22aa6 schema:issueNumber 1
77 rdf:type schema:PublicationIssue
78 N5e97c09b5b1449adbaa5d6f88b78a368 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Antineoplastic Agents
80 rdf:type schema:DefinedTerm
81 N6013503c17e54823b0fcfa3b68ad2350 schema:name nlm_unique_id
82 schema:value 100967800
83 rdf:type schema:PropertyValue
84 N61526b23d16c4609aaf4a75ecbeada2a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Sorafenib
86 rdf:type schema:DefinedTerm
87 N61a3382a854e43d49c19db3716e218c6 schema:name readcube_id
88 schema:value 31e511acfc365bfca268bf88db7e640c7c0466c44b432b766e82f7901565597a
89 rdf:type schema:PropertyValue
90 N7497a794e4de4c7e8ef6686a3381585a schema:name Springer Nature - SN SciGraph project
91 rdf:type schema:Organization
92 N7ef0527a914245dfb4222fc00ed7a587 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Imatinib Mesylate
94 rdf:type schema:DefinedTerm
95 N84be816266d94b288149c290399ce588 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Protein Kinase Inhibitors
97 rdf:type schema:DefinedTerm
98 N84fbaa0deeb84d96822415d05f3d9a35 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Middle Aged
100 rdf:type schema:DefinedTerm
101 N878276fe1d604d72aa9ee633942ac303 schema:name dimensions_id
102 schema:value pub.1010473172
103 rdf:type schema:PropertyValue
104 N8aefc68433b448579174a0efb9732ffe rdf:first sg:person.0677574257.10
105 rdf:rest Nc138388689a6452e9289804893a37d79
106 N9e399ae794534d58b36c325494ea01e0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Graves Disease
108 rdf:type schema:DefinedTerm
109 Nb2389af2a852489d9148c0b1dc0bb0ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Chordoma
111 rdf:type schema:DefinedTerm
112 Nc138388689a6452e9289804893a37d79 rdf:first sg:person.0601021000.78
113 rdf:rest rdf:nil
114 Ncf6037ab74424d32a7e8fa02680e96fc schema:name pubmed_id
115 schema:value 27558389
116 rdf:type schema:PropertyValue
117 Nda7bd4da823e46f38b1058a0d08fdea8 schema:name Department of Medicine, Division of adult oncology, Oscar Lambret Institute, Lille, France
118 rdf:type schema:Organization
119 Ne7db580ab1944eb494f0871bfed05fab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Male
121 rdf:type schema:DefinedTerm
122 Nec470ba382574c0c82d50d6e7c5d2d0e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Niacinamide
124 rdf:type schema:DefinedTerm
125 Nf8f0dddf5700435ea8507b519ab4392d rdf:first sg:person.01046211643.17
126 rdf:rest N8aefc68433b448579174a0efb9732ffe
127 Nfae1e6bf2d8b47c4ab8f083bcc13d249 schema:volumeNumber 16
128 rdf:type schema:PublicationVolume
129 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
130 schema:name Medical and Health Sciences
131 rdf:type schema:DefinedTerm
132 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
133 schema:name Clinical Sciences
134 rdf:type schema:DefinedTerm
135 sg:journal.1024632 schema:issn 1471-2407
136 schema:name BMC Cancer
137 rdf:type schema:Periodical
138 sg:person.01046211643.17 schema:affiliation https://www.grid.ac/institutes/grid.411535.7
139 schema:familyName Castinetti
140 schema:givenName Frederic
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046211643.17
142 rdf:type schema:Person
143 sg:person.016217422035.81 schema:affiliation https://www.grid.ac/institutes/grid.411535.7
144 schema:familyName Eroukhmanoff
145 schema:givenName Juliette
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016217422035.81
147 rdf:type schema:Person
148 sg:person.0601021000.78 schema:affiliation https://www.grid.ac/institutes/grid.411266.6
149 schema:familyName Salas
150 schema:givenName Sebastien
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601021000.78
152 rdf:type schema:Person
153 sg:person.0677574257.10 schema:affiliation Nda7bd4da823e46f38b1058a0d08fdea8
154 schema:familyName Penel
155 schema:givenName Nicolas
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677574257.10
157 rdf:type schema:Person
158 sg:pub.10.1007/s12020-012-9683-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047428945
159 https://doi.org/10.1007/s12020-012-9683-2
160 rdf:type schema:CreativeWork
161 sg:pub.10.1016/j.clpt.2005.06.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031235907
162 https://doi.org/10.1016/j.clpt.2005.06.010
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1016/j.molmed.2005.07.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029510803
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1016/j.molmed.2010.02.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025280461
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1016/j.urolonc.2009.08.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048723986
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1056/nejmoa075853 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039978290
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1080/14653240802317639 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019189330
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1089/thy.2010.0070 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059320792
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1089/thy.2010.0234 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059320861
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1089/thy.2010.0251 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059320869
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1089/thy.2012.0378 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059321511
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1089/thy.2015.0170 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059322048
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1093/annonc/mdm483 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006370749
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1093/jjco/hys076 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015675456
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1093/jnci/djk008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047892911
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1111/j.1365-2265.2008.03253.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1013653892
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1159/000337086 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033631373
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1210/jc.2007-0586 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036876446
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1210/jc.2007-0649 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064289967
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1530/eje-08-0648 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006092842
199 rdf:type schema:CreativeWork
200 https://doi.org/10.7326/0003-4819-145-9-200611070-00008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073709000
201 rdf:type schema:CreativeWork
202 https://www.grid.ac/institutes/grid.411266.6 schema:alternateName Hôpital de la Timone
203 schema:name Aix Marseille Univ, INSERM, U911, Marseille, France
204 Department of Medicine, Division of adult oncology, APHM, Timone Hospital, Marseille, France
205 rdf:type schema:Organization
206 https://www.grid.ac/institutes/grid.411535.7 schema:alternateName Hôpital de la Conception
207 schema:name Department of Medicine, Division of endocrinology, APHM, Conception Hospital, Marseille, France
208 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...